Exploring New Models of Global Clinical Trial Collaboration
As trials become more complex and collaborative, this session explores how Australia’s clinical trial ecosystem is structured, its key strengths and efficiencies, and opportunities for collaboration between German and Australian stakeholders.
Who Should Attend?
Pharmaceutical & biotech R&D leaders
Clinical operations and trial strategy decision-makers CROs and clinical service providers
Academic, hospital, and research institution leaders Policy, innovation, and ecosystem stakeholders
RSVP
To RSVP, please click here to register
Panel Preview
- CTS: Minesh Lalla
Peter MacCallum Cancer Centre
- CRO: Jason Erasmus
Beyond Drug Development
- Lab: Tim Vale
Resolian Bioanalytics
- R&D Tax Advisors: Simone Quin
Prime Financial Group
- Ethics: Jerneen Williams
Bellberry
